Paragon 28 Price to Free Cash Flow Ratio 2020-2022 | FNA
Historical price to free cash flow ratio values for Paragon 28 (FNA) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Paragon 28 Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2023-02-03 | 17.31 | 0.00 | |
| 2022-09-30 | 17.82 | $-1.29 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.346B | $0.147B |
| Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $230.517B | 25.29 |
| Edwards Lifesciences (EW) | United States | $50.772B | 33.11 |
| Alcon (ALC) | Switzerland | $37.369B | 32.17 |
| STERIS (STE) | Ireland | $21.864B | 27.21 |
| Teleflex (TFX) | United States | $12.124B | 19.67 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.123B | 11.16 |
| Penumbra (PEN) | United States | $9.913B | 2372.91 |
| Globus Medical (GMED) | United States | $7.950B | 40.42 |
| Glaukos (GKOS) | United States | $2.458B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 19.55 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.469B | 20.92 |
| Nevro (NVRO) | United States | $1.410B | 0.00 |
| Artivion (AORT) | United States | $0.566B | 0.00 |
